Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Highlights
The global Peripheral Intervention Drug-Eluting Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Peripheral Intervention Drug-Eluting Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Peripheral Intervention Drug-Eluting Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Peripheral Intervention Drug-Eluting Devices include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott and The Lubrizol Corporation, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Intervention Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Intervention Drug-Eluting Devices.
The Peripheral Intervention Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peripheral Intervention Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Intervention Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
Segment by Type
Drug-Eluting Balloons
Drug-Eluting Stents
Segment by Application
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peripheral Intervention Drug-Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peripheral Intervention Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Value Comparison by Type (2023-2029)
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Value by Application: (2023-2029)
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2018-2029
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2018-2029
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Peripheral Intervention Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturers (2018-2023)
2.4 Global Peripheral Intervention Drug-Eluting Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Intervention Drug-Eluting Devices, Product Type & Application
2.7 Peripheral Intervention Drug-Eluting Devices Market Competitive Situation and Trends
2.7.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue
2.7.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2018-2029
3.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2018-2023
3.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Region: 2024-2029
3.3 Global Peripheral Intervention Drug-Eluting Devices Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2018-2029
3.3.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2018-2023
3.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Region: 2024-2029
3.4 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 North America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Peripheral Intervention Drug-Eluting Devices Sales by Country (2018-2029)
3.4.3 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.5.1 Europe Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country (2018-2029)
3.5.3 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Latin America Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country (2018-2029)
3.7.3 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2018-2029)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2018-2023)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2024-2029)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2018-2029)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2018-2029)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2018-2023)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2024-2029)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2018-2029)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2018-2029)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2018-2023)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2024-2029)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2018-2029)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2018-2029)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2018-2023)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Application (2024-2029)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2018-2029)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Corporation Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Biosensors International Group Ltd.
6.6.1 Biosensors International Group Ltd. Corporation Information
6.6.2 Biosensors International Group Ltd. Description and Business Overview
6.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.6.5 Biosensors International Group Ltd. Recent Developments/Updates
6.7 C.R. Bard, Inc.
6.6.1 C.R. Bard, Inc. Corporation Information
6.6.2 C.R. Bard, Inc. Description and Business Overview
6.6.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.7.5 C.R. Bard, Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 The Lubrizol Corporation
6.9.1 The Lubrizol Corporation Corporation Information
6.9.2 The Lubrizol Corporation Description and Business Overview
6.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.9.5 The Lubrizol Corporation Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis
7.2 Peripheral Intervention Drug-Eluting Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Intervention Drug-Eluting Devices Production Mode & Process
7.4 Peripheral Intervention Drug-Eluting Devices Sales and Marketing
7.4.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
7.4.2 Peripheral Intervention Drug-Eluting Devices Distributors
7.5 Peripheral Intervention Drug-Eluting Devices Customers
8 Peripheral Intervention Drug-Eluting Devices Market Dynamics
8.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
8.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
8.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
8.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation
听
听
*If Applicable.
